130 related articles for article (PubMed ID: 9413189)
1. Cisplatin and mild hyperthermia in radiosensitization to low dose rate irradiation in human ovarian carcinoma cells.
Raaphorst GP; Miao J; Ng CE
Anticancer Res; 1997; 17(5A):3469-72. PubMed ID: 9413189
[TBL] [Abstract][Full Text] [Related]
2. Concomitant treatment with mild hyperthermia, cisplatin and low dose-rate irradiation in human ovarian cancer cells sensitive and resistant to cisplatin.
Raaphorst GP; Maio J; Ng CE; Stewart DJ
Oncol Rep; 1998; 5(4):971-7. PubMed ID: 9625857
[TBL] [Abstract][Full Text] [Related]
3. Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells.
Raaphorst GP; Miao J; Stewart D; Ng CE
Cancer Chemother Pharmacol; 1998; 41(6):491-6. PubMed ID: 9554594
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of chronic thermotolerance by KNK437, a benzylidene lactam compound, enhances thermal radiosensitization in mild temperature hyperthermia combined with low dose-rate irradiation.
Sakurai H; Kitamoto Y; Saitoh J; Nonaka T; Ishikawa H; Kiyohara H; Shioya M; Fukushima M; Akimoto T; Hasegawa M; Nakano T
Int J Radiat Biol; 2005 Sep; 81(9):711-8. PubMed ID: 16368649
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic enhancement of low dose-rate irradiation in human lung cancer cells by mild hyperthermia.
Sakurai H; Mitsuhashi N; Kitamoto Y; Nonaka T; Harashima K; Higuchi K; Muramatsu H; Ebara T; Ishikawa H; Niibe H
Anticancer Res; 1998; 18(4A):2525-8. PubMed ID: 9703904
[TBL] [Abstract][Full Text] [Related]
6. Effect of 41 degrees C and 43 degrees C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin.
Bergs JW; Haveman J; Ten Cate R; Medema JP; Franken NA; Van Bree C
Oncol Rep; 2007 Jul; 18(1):219-26. PubMed ID: 17549371
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cross-resistance between responses to cisplatin, hyperthermia, and radiation in human glioma cells and eight clones selected for cisplatin resistance.
Raaphorst GP; Wilkins DE; Mao JP; Miao JC; Ng CE
Radiat Oncol Investig; 1999; 7(3):153-7. PubMed ID: 10406056
[TBL] [Abstract][Full Text] [Related]
8. Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin.
Caney C; Singh G; Lukka H; Rainbow AJ
Int J Radiat Biol; 2004 Apr; 80(4):291-9. PubMed ID: 15204706
[TBL] [Abstract][Full Text] [Related]
9. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin.
Chen G; Zeller WJ; Todorov DK
Anticancer Res; 1993; 13(5A):1269-75. PubMed ID: 8239496
[TBL] [Abstract][Full Text] [Related]
10. The response of human breast tumour cell lines with altered polymerase beta levels to cisplatin and radiation.
Raaphorst GP; Cybulski SE; Sobol R; Ng CE
Anticancer Res; 2001; 21(3B):2079-83. PubMed ID: 11497301
[TBL] [Abstract][Full Text] [Related]
11. Concomitant low dose-rate irradiation and cisplatin treatment in ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment.
Raaphorst GP; Wang G; Stewart D; Ng CE
Int J Radiat Biol; 1996 May; 69(5):623-31. PubMed ID: 8648250
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy as a cisplatin-sensitizer in a resistant ovarian carcinoma cell line.
Siler DF; Wheeless CR; Dubin NH
Cancer; 1996 May; 77(9):1850-3. PubMed ID: 8646684
[TBL] [Abstract][Full Text] [Related]
13. A comparison of hyperthermia cisplatin sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment.
Raaphorst GP; Doja S; Davis L; Stewart D; Ng CE
Cancer Chemother Pharmacol; 1996; 37(6):574-80. PubMed ID: 8612312
[TBL] [Abstract][Full Text] [Related]
14. Sub-additive effect of the combination of radiation and cisplatin in cultured murine and human cell lines.
Gorodetsky R; Mou X; Pfeffer MR; Peretz T; Levy-Agababa F; Vexler AM
Isr J Med Sci; 1995; 31(2-3):95-100. PubMed ID: 7744601
[TBL] [Abstract][Full Text] [Related]
15. Response to pulsed dose rate and low dose rate irradiation with and without mild hyperthermia using human breast carcinoma cell lines.
Niedbala M; McNamee JP; Raaphorst GP
Int J Hyperthermia; 2006 Feb; 22(1):61-75. PubMed ID: 16423753
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermic modulation of resistance to cis-diamminedichloroplatinum (II) in human larynx carcinoma cells.
Beketić-Oresković L; Jaksić M; Oresković S; Osmak M
Int J Hyperthermia; 1997; 13(2):205-14. PubMed ID: 9147146
[TBL] [Abstract][Full Text] [Related]
17. Combined effect of hyperthermia at 42 degrees C and irradiation dose of 2 Gy on two rat yolk sac tumor cell lines with different radio-thermosensitivity in vitro.
Tamaki Y; Mitsuhashi N; Sakurai H; Islam MS; Takahashi T; Akimoto T; Ishikawa H; Saitoh J; Muramatsu H; Niibe H
Anticancer Res; 2002; 22(6A):3143-8. PubMed ID: 12530057
[TBL] [Abstract][Full Text] [Related]
18. Comparison of human tumour cell responses to cisplatin and ZD0473 with and without irradiation.
Raaphorst GP; Yang DP; Li LF; Malone S
Anticancer Res; 2004; 24(2B):613-8. PubMed ID: 15161002
[TBL] [Abstract][Full Text] [Related]
19. Resistance patterns between cis-diamminedichloroplatinum(II) and ionizing radiation.
De Pooter CM; Scalliet PG; Elst HJ; Huybrechts JJ; Gheuens EE; Van Oosterom AT; Fichtinger-Schepman AM; De Bruijn EA
Cancer Res; 1991 Sep; 51(17):4523-7. PubMed ID: 1873796
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of apoptosis in four human tumour cell lines with differing sensitivities to cisplatin.
Raaphorst GP; Mao J; Yang H; Goel R; Niknafs B; Shirazi FH; Yazdi HM; Rippstein P; Ng CE
Anticancer Res; 1998; 18(4C):2945-51. PubMed ID: 9713489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
